Cartesian Therapeutics (NASDAQ:RNAC – Get Free Report) issued its quarterly earnings data on Thursday. Cartesian Therapeutics Price PerformanceShares of Cartesian Therapeutics stock traded up $0.09 during trading on Friday, hitting $8.85. Cartesian Therapeutics has a 52 week low of $5.60 and a 52 week high of $12.25. Wall Street Zen upgraded Cartesian Therapeutics from a “sell” rating to a “hold” rating in a research note on Saturday. Featured StoriesReceive News & Ratings for Cartesian Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cartesian Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.